Silence Therapeutics (SLN) Research & Development (2024 - 2026)
Silence Therapeutics' Research & Development came in at $9.15 million for the quarter ended Jun 30, 2026, down 48.2% from $17.65 million a year earlier but up 0.3% from the prior quarter.
Silence Therapeutics (SLN) Research & Development (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Silence Therapeutics reported Research & Development of $47.56 million, down 41.1% year-over-year; for the year ended Dec 31, 2025, it came in at $67.75 million, down 0.2% from the prior year.
- Research & Development carries a five-year compound annual growth rate of 21.2% (years ended Dec 2020 to Dec 2025).
- Going back by year, Research & Development was $67.88 million in the year ended Dec 31, 2024 (+19.2%), $56.94 million in the year ended Dec 31, 2023 (+30.7%), $43.55 million in the year ended Dec 31, 2022 (+2.9%) and $42.33 million in the year ended Dec 31, 2021 (+63.1%).
- The five-year range for quarterly Research & Development is $8.75 million (the quarter ended Dec 31, 2025) to $22.08 million (the quarter ended Dec 31, 2024).
- Year-over-year, Research & Development has declined for three consecutive quarters, with an average decline of 9.9% over the last six quarters.
- Business Quant data shows SLN's Research & Development at $9.12 million (quarter ended Mar 31, 2026), $8.75 million (quarter ended Dec 31, 2025) and $20.54 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Silence Therapeutics | 529.16 Mn | 457.06 Mn | - | 9.15 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.15 Mn |
| Mar 31, 2026 | 9.12 Mn |
| Dec 31, 2025 | 8.75 Mn |
| Sep 30, 2025 | 20.54 Mn |
| Jun 30, 2025 | 17.65 Mn |
| Mar 31, 2025 | 20.81 Mn |
| Dec 31, 2024 | 22.08 Mn |
| Sep 30, 2024 | 20.16 Mn |
| Jun 30, 2024 | 13.80 Mn |
| Mar 31, 2024 | 11.85 Mn |
Silence Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();